Filing Details
- Accession Number:
- 0001127602-11-027827
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-10-28 12:03:28
- Reporting Period:
- 2011-10-26
- Filing Date:
- 2011-10-28
- Accepted Time:
- 2011-10-28 12:03:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 912183 | Cubist Pharmaceuticals Inc | CBST | Pharmaceutical Preparations (2834) | 223192085 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1386932 | Santosh Vetticaden | 65 Hayden Avenue Lexington MA 02421 | Svp & Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-10-26 | 55,000 | $22.66 | 63,433 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-10-26 | 55,000 | $38.60 | 8,433 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2011-10-26 | 55,000 | $0.00 | 55,000 | $22.66 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,000 | 2009-04-15 | 2019-01-15 | No | 4 | M | Direct |
Footnotes
- Option vests 6.25% quarterly over a four-year period.
- This transaction was executed in multiple trades at prices ranging from $38.1850 to $38.81. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
